Robert Shumaker
Impact in
- Obstetrics and Gynecology top 2%
- Endometrial and Cervical Cancer Treatments
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Hydrocarbon exploration and reservoir analysis 7
- Co-authors
- Corina E. Dutcus (4 shared papers)Matthew Hiram Taylor (3 shared papers)Vicky Makker (3 shared papers)Daniel E. Stepan (3 shared papers)Drew Warren Rasco (2 shared papers)Jane Wu (2 shared papers)Allen Lee Cohn (2 shared papers)Marcia S. Brose (2 shared papers)
- Journals
- AAPG Bulletin (5 papers)British Journal of Clinical Pharmacology (2 papers)The Journal of Clinical Pharmacology (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Robert Shumaker
40 papers receiving 2.0k citations
Robert Shumaker's Hit Papers
Peers
Comparison fields: 5 of 105
- Obstetrics and Gynecology 316
- Oncology 684
- Hepatology 160
- Reproductive Medicine 162
- Pharmacology 122
Countries citing papers authored by Robert Shumaker
This map shows the geographic impact of Robert Shumaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Shumaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Shumaker more than expected).
Fields of papers citing papers by Robert Shumaker
This network shows the impact of papers produced by Robert Shumaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Shumaker. The network helps show where Robert Shumaker may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Shumaker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer Hit paper breakdown → | 2020 | 412 |
| 2 | Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial Hit paper breakdown → | 2019 | 399 |
| 3 | Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors Hit paper breakdown → | 2020 | 346 |
| 4 | 2014 | 70 | |
| 5 | 2016 | 66 | |
| 6 | 2017 | 64 | |
| 7 | 2015 | 62 | |
| 8 | 2014 | 53 | |
| 9 | 2014 | 52 | |
| 10 | 1976 | 49 | |
| 11 | 2014 | 47 | |
| 12 | 1994 | 44 | |
| 13 | 1994 | 43 | |
| 14 | 1992 | 40 | |
| 15 | 2000 | 39 | |
| 16 | 2012 | 38 | |
| 17 | 2014 | 32 | |
| 18 | 1996 | 29 | |
| 19 | 1992 | 26 | |
| 20 | 2018 | 20 |
About Robert Shumaker
Robert Shumaker is a scholar working on Pharmacology, Mechanics of Materials, Geophysics, Earth-Surface Processes and Statistics and Probability, having authored 41 papers that have together received 2.1k indexed citations. Recurring topics across this work include Hydrocarbon exploration and reservoir analysis (7 papers), Plant Toxicity and Pharmacological Properties (6 papers), Geological and Geochemical Analysis (4 papers), Statistical Methods in Clinical Trials (3 papers), Geological formations and processes (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). The work is most often cited by research in Obstetrics and Gynecology (316 citations), Oncology (684 citations), Hepatology (160 citations), Reproductive Medicine (162 citations) and Pharmacology (122 citations). Robert Shumaker has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Corina E. Dutcus, Matthew Hiram Taylor, Vicky Makker, Daniel E. Stepan, Drew Warren Rasco, Jane Wu, Allen Lee Cohn, Marcia S. Brose, Emmett V. Schmidt and Carol A Aghajanian. Their work appears in journals such as AAPG Bulletin, British Journal of Clinical Pharmacology, The Journal of Clinical Pharmacology, Cancer Chemotherapy and Pharmacology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.